| The therapeutic potential of naringenin: a review of clinical trials B Salehi, PVT Fokou, M Sharifi-Rad, P Zucca, R Pezzani, N Martins, ... Pharmaceuticals 12 (1), 11, 2019 | 766 | 2019 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 665 | 2022 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 307 | 2024 |
| Clinical applications of artificial intelligence and machine learning in cancer diagnosis: looking into the future MJ Iqbal, Z Javed, H Sadia, IA Qureshi, A Irshad, R Ahmed, K Malik, ... Cancer cell international 21 (1), 270, 2021 | 277 | 2021 |
| Bioactive Compounds and Health Benefits of Artemisia Species M Nigam, M Atanassova, AP Mishra, R Pezzani, HP Devkota, S Plygun, ... Natural product communications 14 (7), 1934578X19850354, 2019 | 239 | 2019 |
| Synergistic effects of plant derivatives and conventional chemotherapeutic agents: an update on the cancer perspective R Pezzani, B Salehi, S Vitalini, M Iriti, FA Zuñiga, J Sharifi-Rad, ... Medicina 55 (4), 110, 2019 | 229 | 2019 |
| Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study E Mercuri, S Messina, C Bruno, M Mora, E Pegoraro, GP Comi, A D'Amico, ... Neurology 72 (21), 1802-1809, 2009 | 203 | 2009 |
| Programmed cell death, from a cancer perspective: an overview AP Mishra, B Salehi, M Sharifi-Rad, R Pezzani, F Kobarfard, J Sharifi-Rad, ... Molecular diagnosis & therapy 22, 281-295, 2018 | 175 | 2018 |
| Effect of KCNJ5 Mutations on Gene Expression in Aldosterone-Producing Adenomas and Adrenocortical Cells S Monticone, NG Hattangady, K Nishimoto, F Mantero, B Rubin, ... The Journal of Clinical Endocrinology & Metabolism 97 (8), E1567-E1572, 2012 | 172 | 2012 |
| Bioactivities of Origanum vulgare L.: an update R Pezzani, S Vitalini, M Iriti Phytochemistry reviews 16, 1253-1268, 2017 | 152 | 2017 |
| The Wonderful Activities of the Genus Mentha: Not Only Antioxidant Properties M Tafrihi, M Imran, T Tufail, TA Gondal, G Caruso, S Sharma, R Sharma, ... Molecules 26 (4), 1118, 2021 | 137 | 2021 |
| Phytotherapeutics in cancer invasion and metastasis B Salehi, P Zucca, M Sharifi‐Rad, R Pezzani, S Rajabi, WN Setzer, ... Phytotherapy Research 32 (8), 1425-1449, 2018 | 136 | 2018 |
| Myricetin: A comprehensive review on its biological potentials M Imran, F Saeed, G Hussain, A Imran, Z Mehmood, TA Gondal, ... Food science & nutrition 9 (10), 5854-5868, 2021 | 128 | 2021 |
| Preclinical activities of epigallocatechin gallate in signaling pathways in cancer M Sharifi-Rad, R Pezzani, M Redaelli, M Zorzan, M Imran, A Ahmed Khalil, ... Molecules 25 (3), 467, 2020 | 106 | 2020 |
| Anti-ganglioside antibodies in coeliac disease with neurological disorders U Volta, R De Giorgio, A Granito, V Stanghellini, G Barbara, P Avoni, ... Digestive and Liver Disease 38 (3), 183-187, 2006 | 88 | 2006 |
| Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors P Perge, H Butz, R Pezzani, I Bancos, Z Nagy, K Pálóczi, G Nyírő, ... Scientific reports 7 (1), 5474, 2017 | 72 | 2017 |
| Overexpression of L-type amino acid transporter 1 (LAT1) and 2 (LAT2): novel markers of neuroendocrine tumors S Barollo, L Bertazza, S Watutantrige-Fernando, S Censi, E Cavedon, ... PloS one 11 (5), e0156044, 2016 | 68 | 2016 |
| Combination of sorafenib and everolimus impacts therapeutically on adrenocortical tumor models B Mariniello, A Rosato, G Zuccolotto, B Rubin, MV Cicala, I Finco, ... Endocrine Related Cancer 19 (4), 527, 2012 | 67 | 2012 |
| BRAFK601E Mutation in a Patient with a Follicular Thyroid Carcinoma G Pennelli, F Vianello, S Barollo, R Pezzani, I Merante Boschin, ... Thyroid 21 (12), 1393-1396, 2011 | 64 | 2011 |
| Phenolic compounds as Nrf2 inhibitors: potential applications in cancer therapy J Sharifi-Rad, V Seidel, M Izabela, M Monserrat-Mequida, A Sureda, ... Cell Communication and Signaling 21 (1), 89, 2023 | 63 | 2023 |
Javad Sharifi-RadПотвърден имейл адрес: uazuay.edu.ec